An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants

被引:26
|
作者
Tallei, Trina Ekawati [1 ,2 ]
Fatimawali [2 ,3 ]
Yelnetty, Afriza [4 ]
Idroes, Rinaldi [5 ]
Kusumawaty, Diah [6 ]
Bin Emran, Talha [7 ]
Yesiloglu, Talha Zahid [8 ]
Sippl, Wolfgang [8 ]
Mahmud, Shafi [9 ]
Alqahtani, Taha [10 ]
Alqahtani, Ali M. [10 ]
Asiri, Saeed [11 ]
Rahmatullah, Mohammed [12 ]
Jahan, Rownak [12 ]
Khan, Md Arif [12 ]
Celik, Ismail [13 ]
机构
[1] Sam Ratulangi Univ, Fac Math & Nat Sci, Dept Biol, Manado, Indonesia
[2] Sam Ratulangi Univ, Univ Ctr Excellence Biotechnol & Conservat Wallac, Inst Res & Community Serv, Manado, Indonesia
[3] Sam Ratulangi Univ, Fac Math & Nat Sci, Pharm Study Program, Manado, Indonesia
[4] Sam Ratulangi Univ, Fac Anim Husb, Dept Anim Prod, Manado, Indonesia
[5] Univ Syiah Kuala, Fac Math & Nat Sci, Dept Pharm, Banda Aceh, Indonesia
[6] Univ Pendidikan Indonesia, Fac Math & Nat Sci Educ, Dept Biol, Bandung, Indonesia
[7] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong, Bangladesh
[8] Martin Luther Univ Halle Wittenberg, Inst Pharm, Halle, Germany
[9] Univ Rajshahi, Dept Genet Engn & Biotechnol, Microbiol Lab, Rajshahi, Bangladesh
[10] King Khalid Univ, Coll Pharm, Dept Pharmacol, Abha, Saudi Arabia
[11] Najran Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Najran, Saudi Arabia
[12] Univ Dev Alternat, Dept Biotechnol & Genet Engn, Dhaka, Bangladesh
[13] Erciyes Univ, Fac Pharm, Dept Pharmaceut Chem, Kayseri, Turkey
关键词
bromelain; receptor-binding domain; SARS-CoV-2; mutation; variants; WEB SERVER; BINDING-AFFINITY; PROTEIN; CLUSPRO; VIRUS;
D O I
10.3389/fphar.2021.717757
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as well as several other important parts of this virus, have recently undergone mutations, resulting in new virus variants. While no treatment is currently available, a naturally derived molecule with known antiviral properties could be used as a potential treatment. Bromelain is an enzyme found in the fruit and stem of pineapples. This substance has been shown to have a broad antiviral activity. In this article, we analyse the ability of bromelain to counteract various variants of the SARS-CoV-2 by targeting bromelain binding on the side of this viral interaction with human angiotensin-converting enzyme 2 (hACE2) using molecular docking and molecular dynamics simulation approaches. We have succeeded in making three-dimensional configurations of various RBD variants using protein modelling. Bromelain exhibited good binding affinity toward various variants of RBDs and binds right at the binding site between RBDs and hACE2. This result is also presented in the modelling between Bromelain, RBD, and hACE2. The molecular dynamics (MD) simulations study revealed significant stability of the bromelain and RBD proteins separately up to 100 ns with an RMSD value of 2 angstrom. Furthermore, despite increases in RMSD and changes in Rog values of complexes, which are likely due to some destabilized interactions between bromelain and RBD proteins, two proteins in each complex remained bonded, and the site where the two proteins bind remained unchanged. This finding indicated that bromelain could have an inhibitory effect on different SARS-CoV-2 variants, paving the way for a new SARS-CoV-2 inhibitor drug. However, more in vitro and in vivo research on this potential mechanism of action is required.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Dynamics and binding affinity of nucleoside and non-nucleoside inhibitors with RdRp of SARS-CoV-2: a molecular screening, docking, and molecular dynamics simulation study
    Chinnamadhu, Archana
    Ramakrishnan, Jaganathan
    Suresh, Suganya
    Ramadurai, Prakash
    Poomani, Kumaradhas
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (20): : 10396 - 10410
  • [22] Molecular docking and molecular dynamics simulation studies reveal repurposing I-Motif ligand as a promising protease inhibitor against SARS-CoV-2 variants
    Prompat, Napat
    Nadee, Panik
    Phongdara, Amornrat
    Nualla-ong, Aekkaraj
    MOLECULAR SIMULATION, 2024, 50 (16) : 1354 - 1366
  • [23] Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab
    Antonelli, Guido
    Anastasi, Emanuela
    Ciprani, Fabrizio
    Cabral, Rodolfo J. Riveros
    Ialongo, Cristiano
    Capobianchi, Maria R.
    Turriziani, Ombretta
    Angeloni, Antonio
    LANCET MICROBE, 2021, 2 (05): : E178 - E178
  • [24] In-silico study: docking simulation and molecular dynamics of peptidomimetic fullerene-based derivatives against SARS-CoV-2 Mpro
    Saleh, Noha A.
    3 BIOTECH, 2023, 13 (06)
  • [25] In-silico study: docking simulation and molecular dynamics of peptidomimetic fullerene-based derivatives against SARS-CoV-2 Mpro
    Noha A. Saleh
    3 Biotech, 2023, 13
  • [26] Conformational and Stability Analysis of SARS-CoV-2 Spike Protein Variants by Molecular Simulation
    Olivos-Ramirez, Gustavo E.
    Cofas-Vargas, Luis F.
    Madl, Tobias
    Poma, Adolfo B.
    PATHOGENS, 2025, 14 (03):
  • [27] Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis
    Sharma, Ganesh
    Kumar, Neeraj
    Sharma, Chandra Shekhar
    Alqahtani, Taha
    Tiruneh, Yewulsew Kebede
    Sultana, Sharifa
    Rolim Silva, Gabriel Vinicius
    Menezes, Gabriela de Lima
    Zaki, Magdi E. A.
    Oliveira, Jonas Ivan Nobre
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [28] RETRACTED: A Study of Potential SARS-CoV-2 Antiviral Drugs and Preliminary Research of Their Molecular Mechanism, Based on Anti-SARS-CoV Drug Screening and Molecular Dynamics Simulation (Retracted Article)
    Zhao, Xiaomeng
    Liu, Ruixia
    Miao, Zhi
    Ye, Nan
    Lu, Wenyu
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2020, 27 (12) : E1699 - E1713
  • [29] Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
    Omer, Samia E.
    Ibrahim, Tawasol M.
    Krar, Omer A.
    Ali, Amna M.
    Makki, Alaa A.
    Ibraheem, Walaa
    Alzain, Abdulrahim A.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 29
  • [30] Elucidating the molecular docking and binding dynamics of aptamers with spike proteins across SARS-CoV-2 variants of concern
    Quintela, Irwin A.
    Vasse, Tyler
    Jian, Dana
    Harrington, Cameron
    Sien, Wesley
    Wu, Vivian C. H.
    FRONTIERS IN MICROBIOLOGY, 2025, 16